•  Login
  •  Register

Hematology of Newborn

₹ 1000.00

Category
Medical CME Programs

  • Duration 90 Days
  • Modules 17

Hematology of NewBorn:Hematology is the study of diseases that affect the blood, blood-forming processes, and blood. Both adult and paediatric surgeons frequently deal with hematologic issues related to wound healing, inflammation, and haemostasis. This comprehensive Course module on the pathophysiology, recognition, and therapy of hematopoietic disorders in the new-born was written by practising physicians specialised in paediatric haematology, neonatology, immunology, paediatric infectious disease, and transfusion medicine. This course content is restricted to an overview of neonatal hematopoiesis and hemostasis, comparing and contrasting the similarities and differences observed between neonatal and adult populations due to the complexity and diversity of haematology.
Target audience: Oncology/gynaecology-Health-system/ Health-Care Providers
Type of activity: Application
Faculty:
Release date: 
Expiration date: 
Time to complete activity: Self-pace
Fee: 
Learning Outcomes:
This Professional-CME offers a surgeon-directed study of new-born hematopoiesis, as well as an overview of current knowledge of their hemostatic characteristics under normal and pathologic settings.
The emphasis is on clinical challenges faced by paediatric experts. There are chapters on leukocyte disorders, platelet disorders, procoagulant and anticoagulant proteins, and red blood cell disorders.
Neonatal transfusion, newborn malignant diseases, neonatal hemoglobinopathy screening, and harvesting and storing umbilical-cord stem cells are also reviewed, as are practical approaches to diagnosis and treatment.
Educational Disclaimer: CME activities don't count as professional advice or referrals; they are only offered for educational content. Discussions on medications, dosing, and procedures may have relied on the author(s)' clinical experience, professional literature, or other sources. They may also point to exploratory applications that lack official labelling or indications. Participants are advised to refer to authoritative sources or in-depth prescription information websites